Observational studyActa dermato-venereologica2024

Tildrakizumab Treatment for Psoriasis in Real-world Practice: An Analysis from the Swiss Registry (SDNTT).

Julia-Tatjana Maul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.